These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

92 related items for PubMed ID: 2877832

  • 1. N-(4-hydroxyphenyl)-all-trans-retinamide pharmacokinetics in female rats and mice.
    Hultin TA, May CM, Moon RC.
    Drug Metab Dispos; 1986; 14(6):714-7. PubMed ID: 2877832
    [Abstract] [Full Text] [Related]

  • 2. Distribution and metabolism of the retinoid, N-(4-methoxyphenyl)-all-trans-retinamide, the major metabolite of N-(4-hydroxyphenyl)-all-trans-retinamide, in female mice.
    Hultin TA, Filla MS, McCormick DL.
    Drug Metab Dispos; 1990; 18(2):175-9. PubMed ID: 1971569
    [Abstract] [Full Text] [Related]

  • 3. Effects of pretreatment with the retinoid N-(4-hydroxyphenyl)-all-trans-retinamide and phenobarbital on the disposition and metabolism of N-(4-hydroxyphenyl)-all-trans-retinamide in mice.
    Hultin TA, McCormick DL, May CM, Moon RC.
    Drug Metab Dispos; 1988; 16(6):783-8. PubMed ID: 2907453
    [Abstract] [Full Text] [Related]

  • 4. Liquid chromatography method for quantifying N-(4-hydroxyphenyl)retinamide and N-(4-methoxyphenyl)retinamide in tissues.
    Vratilova J, Frgala T, Maurer BJ, Patrick Reynolds C.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Sep 05; 808(2):125-30. PubMed ID: 15261805
    [Abstract] [Full Text] [Related]

  • 5. Biotransformation and biological activity of N-(4-hydroxyphenyl)retinamide derivatives in rodents.
    Swanson BN, Newton DL, Roller PP, Sporn MB.
    J Pharmacol Exp Ther; 1981 Dec 05; 219(3):632-7. PubMed ID: 6170750
    [Abstract] [Full Text] [Related]

  • 6. Pharmacokinetics of N-(4-hydroxyphenyl)-all-trans-retinamide in rats.
    Swanson BN, Zaharevitz DW, Sporn MB.
    Drug Metab Dispos; 1980 Dec 05; 8(3):168-72. PubMed ID: 6104581
    [Abstract] [Full Text] [Related]

  • 7. Metabolism of the chemopreventive retinoid N-(4-hydroxyphenyl)retinamide by mammary gland in organ culture.
    Mehta RG, Hultin TA, Moon RC.
    Biochem J; 1988 Dec 01; 256(2):579-84. PubMed ID: 2851995
    [Abstract] [Full Text] [Related]

  • 8. Chemoprevention of skin carcinogenesis by phenylretinamides: retinoid receptor-independent tumor suppression.
    Xu H, Cheepala S, McCauley E, Coombes K, Xiao L, Fischer SM, Clifford JL.
    Clin Cancer Res; 2006 Feb 01; 12(3 Pt 1):969-79. PubMed ID: 16467112
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Retinoid metabolism in the prostate: effects of administration of the synthetic retinoid N-(4-hydroxyphenyl)retinamide.
    Lewis KC, Hochadel JF.
    Cancer Res; 1999 Dec 01; 59(23):5947-55. PubMed ID: 10606240
    [Abstract] [Full Text] [Related]

  • 14. Comparative activity of dietary or topical exposure to three retinoids in the promotion of skin tumor induction in mice.
    McCormick DL, Bagg BJ, Hultin TA.
    Cancer Res; 1987 Nov 15; 47(22):5989-93. PubMed ID: 2959358
    [Abstract] [Full Text] [Related]

  • 15. Improved oral delivery of N-(4-hydroxyphenyl)retinamide with a novel LYM-X-SORB organized lipid complex.
    Maurer BJ, Kalous O, Yesair DW, Wu X, Janeba J, Maldonado V, Khankaldyyan V, Frgala T, Sun BC, McKee RT, Burgess SW, Shaw WA, Reynolds CP.
    Clin Cancer Res; 2007 May 15; 13(10):3079-86. PubMed ID: 17505011
    [Abstract] [Full Text] [Related]

  • 16. Retinoid receptor-dependent and independent biological activities of novel fenretinide analogues and metabolites.
    Sabichi AL, Xu H, Fischer S, Zou C, Yang X, Steele VE, Kelloff GJ, Lotan R, Clifford JL.
    Clin Cancer Res; 2003 Oct 01; 9(12):4606-13. PubMed ID: 14555536
    [Abstract] [Full Text] [Related]

  • 17. Effect of N-(4-hydroxyphenyl)retinamide on murine mammary tumor cells in culture.
    Bunk MJ, Telang NT, Higgins PJ, Traganos F, Sarkar NH.
    Nutr Cancer; 1985 Oct 01; 7(1-2):105-15. PubMed ID: 2999720
    [Abstract] [Full Text] [Related]

  • 18. Suppression of rat mammary cancer development by N-(4-hydroxyphenyl)retinamide (4-HPR) following surgical removal of first palpable tumor.
    Moon RC, Pritchard JF, Mehta RG, Nomides CT, Thomas CF, Dinger NM.
    Carcinogenesis; 1989 Sep 01; 10(9):1645-9. PubMed ID: 2527636
    [Abstract] [Full Text] [Related]

  • 19. Disposition of 13-cis-retinoic acid and N-(2-hydroxyethyl)retinamide in mice after oral doses.
    Kalin JR, Wells MJ, Hill DL.
    Drug Metab Dispos; 1982 Sep 01; 10(4):391-8. PubMed ID: 6126340
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.